Price: $0.0000
$0.00
%
|
Day's High:
| 0.00
| Week Perf:
|
|
Day's Low: |
$ 0.00 |
30 Day Perf: |
|
Volume (M): |
0 |
52 Wk High: |
$ 0.00 |
Volume (M$): |
$ 0 |
52 Wk Avg: |
$0.00 |
Open: |
$0.00 |
52 Wk Low: |
$0.00 |
|
|
Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
24 |
Employees |
17 |
Revenues (TTM) (Millions $) |
0 |
Net Income (TTM) (Millions $) |
-3 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Kaya Holdings Inc
Kaya Holdings, Inc., was incorporated in Delaware in 1993 under the name Gourmet
Market, Inc. and has engaged in a number of businesses. Its name was changed
on May 11, 2007 to Netspace International Holdings, Inc. (“Netspace”).
Netspace acquired 100% of the capital stock of Alternative Fuels Americas, Inc.,
a Florida corporation in January 2010 in a stock for stock transaction and issued
100,000 shares of Series C convertible preferred stock to existing shareholders
of the Florida corporation. The Company’s name was changed in October
2010 from Netspace International Holdings, Inc. to Alternative Fuels Americas,
Inc.
In January 2014, KAYS incorporated a subsidiary, Marijuana Holdings Americas,
Inc. a Florida corporation (“MJAI”) to focus on opportunities in
the legal recreational and medical marijuana in the United States. MJAI has
concentrated its efforts in Oregon, where through controlled Oregon limited
liability companies, it initially secured licenses to operate a medical marijuana
dispensary (an “MMD”) and since the advent of legalization of recreational
cannabis use in Oregon, has secured licenses to operate a total of four retail
outlets for the sale of recreational and medical cannabis, as well as each hold
a license for home delivery of cannabis products. Additionally, MJAI has operated
medical Marijuana Grows in Oregon, and KAYS has purchased 26 acres which it
has targeted for development of the Kaya Farms™ Medical and Recreational
Marijuana Grow and Manufacturing Complex. The Company has developed the Kaya
Shack™ brand for its retail operations.
In March 2014, we applied for and were awarded our first license to operate
an MMD and on July 3, 2014 opened our first Kaya Shack™ Medical Marijuana
Dispensary in Portland, Oregon, thereby becoming the first publicly traded U.S.
company to own and operate an MMD. Initial customer acceptance and media coverage
was very positive, including many references to KAYS as the “Starbucks
of Medical Marijuana” by television news stations, news print publications
and online news sources. In March 2015, the Company changed its name to Kaya
Holdings, Inc. to better reflect its new plan of operations.
In April 2015, KAYS commenced its own medical marijuana grow operations for
the cultivation and harvesting of legal marijuana thereby becoming the first
publicly traded U.S. company to own a majority interest in a vertically integrated
legal marijuana enterprise in the United States. In October 2015, concurrent
with Oregon commencing legal sales of recreational marijuana through MMDs, KAYS
opened its second retail operation in Salem, Oregon, our first Kaya Shack™
Marijuana Superstore. Oregon. During 2015, the Company also consolidated its
grow operations and manufacturing operations into a single facility in Portland,
Oregon.
Company Address: 915 Middle River Drive Ft. Lauderdale 33304 FL
Company Phone Number: 892-6911 Stock Exchange / Ticker: AFAI
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Kaya Holdings Inc
The Disastrous Third Quarter Report of a Major Pharmaceutical Preparations Company: An In-Depth AnalysisThe recent financial report released by a significant player in the Pharmaceutical Preparations sector has raised eyebrows across the industry. On September 30, 2024, the company disclosed a harrowing outcome that showcases how quickly fortunes can turn in the pharmaceutical space. This article will delve into the intricate details of the report, its implications, and what it could mean for the company and the sector as a whole. Revenue and Earnings PlummetAccording to the report, the company observed an alarming decline in its financial performance. For the third quarter of 2024, revenue plummeted to $0.00 million, signifying a catastrophic drop in sales. This stark figure signifies how the company has been struggling to generate income, a trend that contrasts sharply with the broader performance of the Pharmaceutical Preparations industry, which, on average, has reported revenue growth in the same period.
|
Kaya Holdings Inc
Investors in the stock market were met with mixed results for the January to March 31 2024 fiscal time-frame. AFAI saw its per share value remain steady at $0.00, showing no change from the previous year. However, the company experienced a decrease in revenue of -41.944%, bringing in $0.03 million compared to $0.05 million the year before. On the other hand, Kaya Holdings Inc reported a net shortfall of $-1.106 million for the same time-frame, a significant difference from the break-even point the company had reached in the previous year. Despite this financial setback, investors should remain optimistic as the company works towards improving its financial performance in future quarters.
|
Kaya Holdings Inc
As the third quarter of the 2023 earnings season wraps up, financial results for AFAI (Kaya Holdings Inc) have been released, providing insight into the company's performance. Despite flat earnings per share compared to the previous year, AFAI displayed a significant improvement in revenue growth. This article will examine the financial results of AFAI and provide context to understand the overall performance. Earnings Details In the third quarter of 2023, AFAI reported earnings per share of $0.00, which remained unchanged from the prior year but also showed no growth from the previous reporting season. While the lack of growth may raise concerns, it is essential to consider the positive aspects of AFAI's financial results.
|
Kaya Holdings Inc
Kaya Holdings Inc, a company operating in the Major Pharmaceutical Preparations sector, faced a challenging fiscal year ending on June 30, 2023. The company reported balanced books of $0.00 per share, which remained consistent compared to the previous year's figure. However, it is worth noting that Kaya Holdings Inc had a net shortfall of $-0.714 million, a significant decrease from the bottom line of $3.070 million recorded in the corresponding reporting period a year before. One of the major concerns for the company was the sharp decline in revenue. AFAI's revenue dropped by -71.762% to $0.06 million from $0.20 million in the same reporting period last year. On a positive note, the company showed a sequential growth of 14.242% in revenue, increasing from $0.05 million in the prior reporting period. Despite this, the revenue growth rate still lags behind the industry average, as the remainder of the Major Pharmaceutical Preparations sector recorded a 3.05% growth in the second quarter of 2023 compared to the same period in 2022.
|
Kaya Holdings Inc
The financial results for the first quarter of the 2023 earnings season indicate some mixed performances. AFAI, a company whose shares had no gain of $0.00 per share, had not shown any improvement compared to the previous year and preceding reporting season. However, Kaya Holdings Inc had achieved a bottom-line of $0.035 million in the same quarter, which shows an increase in net profit versus a net deficit of $-1.098 million in the corresponding reporting season a year ago. The revenue for AFAI has fallen significantly in the first quarter of the 2023 earnings season. It has declined by -74.428% to $0.05 million compared to $0.19 million in the corresponding reporting season a year ago. The decline in revenue is quite steep and indicates a significant challenge that the company may be experiencing.
|
Per Share |
Current |
Earnings (TTM) |
-0.08 $ |
Revenues (TTM) |
0 $
|
Cash Flow (TTM) |
0 $ |
Cash |
-
|
Book Value |
-
|
Dividend (TTM) |
0 $ |
|
Per Share |
|
Earnings (TTM) |
-0.08 $
|
Revenues (TTM) |
0 $ |
Cash Flow (TTM) |
0 $ |
Cash |
-
|
Book Value |
- |
Dividend (TTM) |
0 $ |
|
|
|
|